Sondersammelgebiets-Volltexte
Refine
Year of publication
Document Type
- Article (8056)
- Part of Periodical (3330)
- Review (207)
- Book (191)
- Periodical (46)
- Report (43)
- Working Paper (34)
- Part of a Book (23)
- Conference Proceeding (19)
- Other (13)
- Diploma Thesis (7)
- Course Material (6)
- diplomthesis (5)
- Doctoral Thesis (3)
- Preprint (3)
Language
- German (5919)
- English (5635)
- French (175)
- Spanish (114)
- Multiple languages (100)
- cze (17)
- dut (13)
- Portuguese (10)
- Italian (1)
- Latin (1)
Is part of the Bibliography
- no (11986)
Keywords
- taxonomy (749)
- new species (448)
- morphology (163)
- distribution (126)
- biodiversity (113)
- Odonata (84)
- systematics (82)
- phylogeny (69)
- Pflanzengesellschaften (67)
- new records (61)
Institute
- Biowissenschaften (378)
- Extern (377)
- Institut für Ökologie, Evolution und Diversität (151)
- Senckenbergische Naturforschende Gesellschaft (139)
- Biochemie und Chemie (122)
- Medizin (114)
- Biodiversität und Klima Forschungszentrum (BiK-F) (104)
- Frankfurt Institute for Advanced Studies (FIAS) (45)
- Pharmazie (35)
- Exzellenzcluster Makromolekulare Komplexe (32)
In den hoch entwickelten Industriestaaten wird seit längerem eine dramatische Veränderung der Bevölkerungsstruktur beobachtet. Bei einer Erhöhung der Lebenserwartung und einer gleichzeitigen Abnahme der Geburtenrate verschiebt sich das Verhältnis von jungen zu alten Individuen immer mehr hin zu den Älteren. Längst wird von einem »Ergrauen« oder gar einer »Vergreisung« Europas gesprochen. Hieraus ergeben sich bereits heute schwerwiegende Probleme für die bestehenden Sozial- und Gesundheitssysteme. Diese drohen sich in der Zukunft dramatisch zu verschärfen. Eine Entlastung wird sicher nur dann erreicht werden können, wenn es gelingt, das Auftreten gesundheitlicher Beeinträchtigungen und Erkrankungen nachhaltig zu verhindern oder zumindest zu verzögern und damit eine Verbesserung der Lebensqualität in fortgeschrittenen Lebensabschnitten zu gewährleisten. Entscheidende Voraussetzung zum Erreichen dieser Ziele ist ein grundlegendes Verständnis der Mechanismen biologischen Alterns.
Ob das Alter ein Segen oder ein Fluch ist, darüber gehen seit der Antike die Meinungen auseinander, und es hat nicht an Versuchen gefehlt, für die doch unleugbaren Gebrechen und Gebresten die Gegenrechnung aufzumachen. Auf der einen Seite also Verfall des Körpers, Krankheit, Nachlassen oder Absterben der Sinnesvermögen und des fleischlichen Begehrens, auf der anderen Seite dafür aber Weisheit, Gelassenheit, Gemütsruhe, Abgeklärtheit, Milde, vielleicht Heiterkeit, da nichts mehr erreicht werden will. Prudentia – Klugheit – und Sophrosyne – Beherrschung der Begierden durch Vernunft und Besonnenheit – heißen die altersgemäßen Stichwörter, die vielleicht sogar Handlungsspielräume eröffnen, die den früheren Lebensaltern fehlten. ...
The experience of pain is mediated by a specialized sensory system, the nociceptive system. There is considerable evidence that the cGMP/cGMP kinase I (cGKI) signaling pathway modulates the nociceptive processing within the spinal cord. However, downstream targets of cGKI in this context have not been identified to date. In this study we investigated whether cysteine-rich protein 2 (CRP2) is a downstream effector of cGKI in the spinal cord and is involved in nociceptive processing. Immunohistochemistry of the mouse spinal cord revealed that CRP2 is expressed in superficial laminae of the dorsal horn. CRP2 is colocalized with cGKI and with markers of primary afferent C fibers. Importantly, the majority of CRP2 mRNA-positive dorsal root ganglion (DRG) neurons express cGKI and CRP2 is phosphorylated in a cGMP-dependent manner. To elucidate the functional role of CRP2 in nociception, we investigated the nociceptive behavior of CRP2-deficient (CRP2-/-) mice. Touch perception and acute thermal nociception were unaltered in CRP2-/- mice. However, CRP2-/- mice showed an increased nociceptive behavior in models of persistent pain as compared to wild type mice. Intrathecal administration of cGKI activating cGMP analogs increased the nociceptive behavior in wild type but not in CRP2-/- mice, indicating that the presence of CRP2 was essential for cGMP/cGKI-mediated nociception. These data indicate that CRP2 is a new downstream effector of cGKI-mediated spinal nociceptive processing and point to an inhibitory role of CRP2 in the generation of inflammatory pain.
cGMP- and cAMP-dependent protein kinases (cGK and cAK) mediate the inhibitory effects of endothelium-derived messenger molecules nitric oxide and prostacyclin on platelets. To understand the mechanisms involved in platelet inhibition we searched for new substrates of cGK and cAK. We identified Rap1GAP2, the only GTPase-activating protein of Rap1 in platelets. Rap1 is a guanine-nucleotide binding protein that controls integrin activity, platelet adhesion and aggregation. Rap1GAP2 is required to turn over Rap1-GTP to Rap1-GDP resulting in the inactivation of integrins and reduced cellular adhesion. Using phospho-specific antibodies we demonstrate phosphorylation of endogenous Rap1GAP2 on serine 7 by cGK and cAK in intact platelets. Yeast-two-hybrid screening revealed an interaction of the phosphoserine/-threonine binding adapter protein 14-3-3 with Rap1GAP2, and we mapped the 14-3-3 binding site to the N-terminus of Rap1GAP2 close to the cGK/cAK phosphorylation site. We could show that 14-3-3 binding to Rap1GAP2 requires phosphorylation of serine 9. Platelet activation by ADP and thrombin treatment induces Rap1GAP2 serine 9 phosphorylation and enhances the attachment of 14-3-3 to Rap1GAP2. In contrast, phosphorylation of serine 7 by cGK/cAK leads to the detachment of 14-3-3. Furthermore, Rap1GAP2 serine 7 phosphorylation correlates with the inhibition of Rap1-GTP formation by cGMP and cAMP in platelets. Cell adhesion experiments provide additional evidence that Rap1GAP2 is activated by the detachment of 14-3-3. Point mutants of Rap1GAP2 deficient in 14-3-3 binding inhibit Rap1-mediated cell adhesion significantly stronger than a Rap1GAP2 mutant that binds 14-3-3 constitutively. Our findings define a novel regulatory mechanism that might contribute to both platelet activation and endothelial inhibition of platelet adhesion and aggregation.
Oxidative stress attenuates the NO-cGMP pathway, e.g. in the vascular system, through scavenging of free NO radicals by superoxide O2•-, by inactivation of soluble guanylyl cyclase (sGC) via oxidation of its central Fe2+ ion, and by down-regulation of sGC protein levels. While the former pathways are well established, the molecular mechanisms underlying the latter are still obscure. Using oxidative sGC inhibitor ODQ we demonstrate rapid down-regulation of sGC protein in mammalian cells. Co-incubation with proteasomal inhibitor MG132 results in accumulation of ubiquitinated sGC whereas sGC activator BAY 58–2667 prevents ubiquitination. ODQ-induced down-regulation of sGC is mediated through selective ubiquitination of its b subunit, and BAY 58–2667 abrogates this effect. Ubiquitination of sGC-b is dramatically enhanced by E3 ligase CHIP. Our data indicate that oxidative stress promotes ubiquitination of sGC b subunit through E3 ligase CHIP, and that sGC activator 58–2667 reverts this effect, most likely through stabilization of the heme-free b subunit. Thus the deleterious effects of oxidative stress can be counter-balanced by an activator of a key enzyme of vascular homeostasis.
Bypassing of DNA lesions by damage-tolerant DNA polymerases depends on the interaction of these enzymes with the monoubiquitylated form of the replicative clamp protein, PCNA. We have analyzed the contributions of ubiquitin and PCNA binding to damage bypass and damage-induced mutagenesis in Polymerase {eta} (encoded by RAD30) from the budding yeast Saccharomyces cerevisiae. We report here that a ubiquitin-binding domain provides enhanced affinity for the ubiquitylated form of PCNA and is essential for in vivo function of the polymerase, but only in conjunction with a basal affinity for the unmodified clamp, mediated by a conserved PCNA interaction motif. We show that enhancement of the interaction and function in damage tolerance does not depend on the ubiquitin attachment site within PCNA. Like its mammalian homolog, budding yeast Polymerase {eta} itself is ubiquitylated in a manner dependent on its ubiquitin-binding domain.
To facilitate the measurement of intramolecular distances in solvated RNA systems, a combination of spin-labeling, electron paramagnetic resonance (EPR), and molecular dynamics (MD) simulation is presented. The fairly rigid spin label 2,2,5,5-tetramethyl-pyrrolin-1-yloxyl-3-acetylene (TPA) was base and site specifically introduced into RNA through a Sonogashira palladium catalyzed crosscoupling on column. For this purpose 5-iodouridine, 5-iodo-cytidine and 2-iodo-adenosine phosphoramidites were synthesized and incorporated into RNA-sequences. Application of the recently developed ACE (R) chemistry presented the main advantage to limit the reduction of the nitroxide to an amine during the oligonucleotide automated synthesis and thus to increase substantially the reliability of the synthesis and the yield of labeled oligonucleotides. 4-Pulse Electron Double Resonance (PELDOR) was then successfully used to measure the intramolecular spin–spin distances in six doubly labeled RNA-duplexes. Comparison of these results with our previous work on DNA showed that A- and B-Form can be differentiated. Using an all-atom force field with explicit solvent, MD simulations gave results in good agreement with the measured distances and indicated that the RNA A-Form was conserved despite a local destabilization effect of the nitroxide label. The applicability of the method to more complex biological systems is discussed.